| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |